pharmaphorum

JANUARY 27, 2022

“I observed that my colleagues who were working to develop and validate various clinical applications of virtual reality technology had no venue to publish their work in a way that would reach other scientists grappling with the same issues and constraints,” Greenleaf said.

Production 138

Production Behavioural Health Development Clinical Trials 138

pharmaphorum

APRIL 25, 2022

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Gani started BehaVR in 2016 to create DTx for mental and behavioural health.

Behavioural Health 103

Behavioural Health Production Clinical Trials Clinical Trials 103

pharmaphorum

MARCH 21, 2022

In a crowd of 200 attendees, guests included medical XR start-ups, hospitals, and research universities from around the globe. In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co. About the author .

Behavioural Health 96

Behavioural Health Pharma Companies Life Science FDA Approval 96

pharmaphorum

JANUARY 26, 2021

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Services to manage and make sense of the health data explosion.

Clinical Trials 140

Clinical Trials Clinical Trials Sales Life Science 140

Drug Discovery World

JANUARY 12, 2023

Protas was early off the mark when this non-profit organisation was launched on 24 January to design and deliver large, inclusive, randomised clinical trials, working in collaboration with industry partners, medical charities, patient groups, academic researchers, and frontline clinical teams.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97